Literature DB >> 30555208

Postassault Substance Use and Coping: A Qualitative Study of Sexual Assault Survivors and Informal Support Providers.

Sarah E Ullman1, Katherine Lorenz1, Anne Kirkner1, Erin O'Callaghan1.   

Abstract

This qualitative interview study examined 45 informal support dyads where a sexual assault was disclosed. Data from matched pairs of survivors and their primary informal support provider (e.g., friend, family, significant other), were used to explore the survivor-support provider (SP) perspectives of coping with assault-related distress via substance use and the effects of survivor substance use on the survivor-SP relationship. Results revealed that survivors' use of drinking and/or drugs to cope had both positive and negative effects on survivor-SP relationships. Findings also showed that SPs play various roles in providing support to survivors who cope via substance use, including engaging in substance use with the survivor and efforts to help get help in their recovery from the assault and substance abuse. Suggestions are made for how safe spaces can be provided where survivors and supporters can get information and treatment, whether formal or informal, that addresses sexual assault, PTSD and substance abuse issues in an integrated way.

Entities:  

Keywords:  coping; qualitative dyad; sexual assault; substance use; support provider

Year:  2018        PMID: 30555208      PMCID: PMC6290351          DOI: 10.1080/07347324.2018.1465807

Source DB:  PubMed          Journal:  Alcohol Treat Q        ISSN: 0734-7324


  2 in total

1.  Women's Experiences of Impairment and Incapacitation During Alcohol/Drug-Related Sexual Assaults: Toward a Survivor-Informed Approach to Measurement.

Authors:  Sarah E Ullman; Erin O'Callaghan; Katherine Lorenz
Journal:  Arch Sex Behav       Date:  2019-07-20

2.  Sexual minority substance use disparities: Bisexual women at elevated risk relative to other sexual minority groups.

Authors:  Megan S Schuler; Rebecca L Collins
Journal:  Drug Alcohol Depend       Date:  2019-11-21       Impact factor: 4.492

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.